Stoke Therapeutics (STOK)
(Delayed Data from NSDQ)
$14.63 USD
+0.38 (2.67%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $14.64 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.55 | 0.00% |
Earnings Summary
For their last quarter, Stoke Therapeutics (STOK) reported earnings of -$0.46 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 19.30%. Look out for STOK's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.55 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for STOK
Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy?
STOK: What are Zacks experts saying now?
Zacks Private Portfolio Services